Is a synthetic form of erythropoietin, a hormone naturally produced by the kidneys that stimulates red blood cell production.
Treatment of anemia associated with chronic kidney disease (CKD)
Treatment of anemia in patients receiving chemotherapy for cancer
Treatment of anemia in patients with HIV/AIDS
To increase red blood cell production in patients undergoing surgery who are at risk of blood loss.
Cresp 60mcg Pfs Inj (Darbepoetin Alfa) works by stimulating the production of red blood cells in the bone marrow. It mimics the action of naturally produced erythropoietin, which helps to regulate red blood cell production.
Darbepoetin alfa should be stored in a refrigerator at 2°C to 8°C (36°F to 46°F). Protect from light. Do not freeze.
The dosage of darbepoetin alfa is determined by your doctor and depends on your individual needs.
Darbepoetin alfa is typically given as an injection under the skin (subcutaneously) or into a vein (intravenously).
The frequency of administration is also determined by your doctor and may vary depending on your condition and response to treatment.
It is important to follow your doctor's instructions carefully and use darbepoetin alfa exactly as prescribed.
Redness or swelling at the injection site
In rare cases, serious side effects may occur, including:
Pure red cell aplasia (PRCA) - a condition where the bone marrow stops producing red blood cells
Headache
High blood pressure
Flulike symptoms
Nausea
Vomiting
Diarrhea
Constipation
Muscle aches
Joint pain
Skin rash
Blood clots
Stroke
Heart attack
Darbepoetin alfa may interact with alcohol. It is advisable to discuss alcohol consumption with your doctor.
Darbepoetin alfa may cause dizziness. It is recommended to avoid driving or operating machinery until you know how darbepoetin alfa affects you.
It is not known if darbepoetin alfa is safe for use during pregnancy or breastfeeding. Discuss with your doctor the potential risks and benefits.
Darbepoetin alfa is not typically used in children.
Darbepoetin alfa is used to treat anemia associated with chronic kidney disease. However, it is important to use it with caution in patients with kidney problems.
There is no specific information regarding the use of darbepoetin alfa in patients with liver problems. Discuss with your doctor the potential risks and benefits.
Product Information: Aranesp (darbepoetin alfa)
National Institutes of Health (NIH) - MedlinePlus
Food and Drug Administration (FDA)
